Institut Pasteur researchers working together with Inserm have recently discovered how Shigella, the bacterium responsible for an acute inflammatory disease of the intestine, is able to destroy our initial immune defenses so that it can survive and invade the mucosa. An understanding of such mechanisms opens up useful therapeutic possibilities both for the treatment of shigellosis and for all intestinal infectious diseases.
Learn more by reading the Institut Pasteur press release.
